ATE37185T1 - Kontrazeptive zusammensetzungen auf basis von levo-norgestrel-estern. - Google Patents

Kontrazeptive zusammensetzungen auf basis von levo-norgestrel-estern.

Info

Publication number
ATE37185T1
ATE37185T1 AT84300611T AT84300611T ATE37185T1 AT E37185 T1 ATE37185 T1 AT E37185T1 AT 84300611 T AT84300611 T AT 84300611T AT 84300611 T AT84300611 T AT 84300611T AT E37185 T1 ATE37185 T1 AT E37185T1
Authority
AT
Austria
Prior art keywords
norgestrel
levo
esters
oxime
compositions based
Prior art date
Application number
AT84300611T
Other languages
English (en)
Inventor
Sidney Department Of Ch Archer
Egon Swedish Medica Diczfalusy
Sjukhuset
Josef Department Of Chem Fried
Ellis Avenue South
Guiseppe Benagiano
Pierre Crabbe
Carl Djerassi
Original Assignee
World Health Org
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by World Health Org filed Critical World Health Org
Application granted granted Critical
Publication of ATE37185T1 publication Critical patent/ATE37185T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0016—Oximes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicinal Preparation (AREA)
AT84300611T 1983-05-19 1984-01-31 Kontrazeptive zusammensetzungen auf basis von levo-norgestrel-estern. ATE37185T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB838313921A GB8313921D0 (en) 1983-05-19 1983-05-19 Contraceptive compositions
EP84300611A EP0129947B1 (de) 1983-05-19 1984-01-31 Kontrazeptive Zusammensetzungen auf Basis von Levo-Norgestrel-Estern

Publications (1)

Publication Number Publication Date
ATE37185T1 true ATE37185T1 (de) 1988-09-15

Family

ID=10543055

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84300611T ATE37185T1 (de) 1983-05-19 1984-01-31 Kontrazeptive zusammensetzungen auf basis von levo-norgestrel-estern.

Country Status (4)

Country Link
EP (1) EP0129947B1 (de)
AT (1) ATE37185T1 (de)
DE (1) DE3474024D1 (de)
GB (1) GB8313921D0 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3511588A1 (de) * 1985-03-27 1986-10-02 Schering AG, Berlin und Bergkamen, 1000 Berlin Waessrige kristallsuspension von steroidglykoestern
DE4232521A1 (de) * 1992-09-22 1994-03-24 Schering Ag Gestagen wirksame 4,5;11,12-Estradiene, Verfahren zu ihrer Herstellung, diese Estradiene enthaltende Arzneimittel sowie deren Verwendung zur Herstellung von Arzneimitteln
EP1098653A2 (de) * 1998-07-17 2001-05-16 PHARMACIA & UPJOHN COMPANY Subkutane verabreichung von medroxyprogesteronacetat zur kontrazeption
TW200403065A (en) * 2002-05-30 2004-03-01 Akzo Nobel Nv New etonogestrel esters
EP2399566A1 (de) * 2010-06-28 2011-12-28 Laboratoire HRA Pharma Verfahren zur Empfängnisverhütung einmal im Monat
WO2017147274A1 (en) * 2016-02-24 2017-08-31 Eastern Virginia Medical School An improved formulation of long-acting levonorgestrel butanoate injectable depot suspension
PE20210155A1 (es) * 2017-10-19 2021-01-26 Evestra Inc Anticonceptivos de profarmacos de progestina de accion mas prolongada
US11186585B2 (en) * 2018-08-17 2021-11-30 Kappa-Pharma LLC Compositions and methods of enhancing opioid receptor engagement by opioid hexadienoates and optionally substituted hexadienoates

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4027019A (en) * 1975-07-24 1977-05-31 Ortho Pharmaceutical Corporation 3-Oximes of D-17α-ethynyl-19-nortestosterone esters and method

Also Published As

Publication number Publication date
EP0129947B1 (de) 1988-09-14
EP0129947A3 (en) 1985-05-22
GB8313921D0 (en) 1983-06-22
DE3474024D1 (en) 1988-10-20
EP0129947A2 (de) 1985-01-02

Similar Documents

Publication Publication Date Title
NO944113L (no) Stabilt, hydratisert cefalosporin-tört pulver for oral suspensjonsformulering
HUT37418A (en) Process for producing new 2,2'-imino-bis/ethanol/ derivatives and pharmaceutical compositions sontaining them as active agents
ATE61050T1 (de) Pyridazinamine wirksam gegen viren.
HUT61324A (en) Process for producing rhombic cyclosporin consisting of globular particles and new pulmonary pharmaceutical compositions comprising same as active ingredient
PT1086688E (pt) Formulacoes de aerossol em suspensao
DE69430635D1 (de) Loteprednoletabonat-suspension
ES2055014T3 (es) Productos que contienen psyllium.
HUT41957A (en) Insecticide compositions containing aryl-pyridon derivatives as active agents and process for producing the active agents
ATE37185T1 (de) Kontrazeptive zusammensetzungen auf basis von levo-norgestrel-estern.
HUT47793A (en) Herbicide compositions containing 2,6-substituted-pyridine-carboxylic acid derivatives as active components and process for producing the active components
DK0667155T3 (da) Tabletter med thioctsyre med bestemt kornstørrelse
HUT61024A (en) Process for producing 10(1-hydroxyethyl)-11-oxo-1-aza-tricyclo/7.2.0.0.3.8/undex-2-ene-2-carboxylic acid esters and pharmaceutical compositions comprising same as active ingredient
UA74388C2 (uk) Фармацевтичні композиції тизоксаніду і нітазоксаніду
CA2047802A1 (en) Pharmaceutical compositions
TW325404B (en) Pharmaceutical composition for the safe administration of fatty acids the invention relates to a pharmaceutical composition for the safe administration of fatty acids which is useful in the treatment of cancer, viral infections and other disorders.
HUT63306A (en) Insecticidal compositions comprising guanide derivatives as active ingredient and process for producing the active ingredient
ES8504774A1 (es) Procedimiento para preparar derivados de 2-piperacinil-quinazolina
HUT41376A (en) Insecticide compositions containing phenyl-hidrazine derivatives as active agents and process for producing the active agents
HUT47792A (en) Herbicide compositions containing 2,6-substituted-pyridine-carboxylic acid derivatives as active components and process for producing the active components
FR2515038B1 (fr) A titre de medicaments, certains derives de l'acide 4-phenyl 4-oxo 2-butenoique et compositions les renfermant
IL111138A (en) Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
FR2556592B1 (fr) Compositions pharmaceutiques contenant des derives de l'acide campho-methylidene cinnamique
HUT50807A (en) Process for producing pharmaceutical compositions comprising labdane derivatives as active ingredient and for producing the active ingredient
CA2073673A1 (en) Esters of 2-arylmethyl-1-naphthol derivatives as 5-lipoxygenase inhibitors
EP0141414A3 (de) Haartonikum-Präparat